Clinical Case Reports (Mar 2022)

Metachronous, non‐pineal, trilateral retinoblastoma in a patient with a seemingly reduced‐expressivity RB1 germline deletion

  • Saga Elise Eiset,
  • Mikkel Funding,
  • Hilary Racher,
  • Steffen Heegaard,
  • Brenda Gallie,
  • Steen Fiil Urbak,
  • Pernille A. Gregersen

DOI
https://doi.org/10.1002/ccr3.5498
Journal volume & issue
Vol. 10, no. 3
pp. n/a – n/a

Abstract

Read online

Abstract The clinical course of trilateral retinoblastoma can be unpredictable, and expressivity of germline RB1 variants may vary during development. We describe an unexpected fatal case of trilateral retinoblastoma with an intracranial tumor in an unusual location and discuss genetic copy number analyses as a useful diagnostic tool with therapeutic potential.

Keywords